Trials that matter: Can patients with venous thromboembolism be treated with fixed-dose subcutaneous unfractionated heparin?

被引：3
|
作者：
Goldhaber, Samuel Z. [1 ]
Berkwits, Michael [1 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2006年 / 145卷 / 12期
关键词：
D O I：
10.7326/0003-4819-145-12-200612190-00011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：929 / 931
页数：3
相关论文
共 50 条
  • [21] Safety of High-Dose Unfractionated Heparin for Prophylaxis of Venous Thromboembolism in Hospitalized Obese Patients
    Regis, Teresa
    Goriacko, Pavel
    Ferguson, Nadia
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (08) : 963 - 969
  • [22] Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism
    Bernardi, E
    Prandoni, P
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (05) : 363 - 367
  • [23] Subcutaneous Unfractionated Heparin for Treatment of Venous Thromboembolism in End-Stage Renal Disease
    Metzger, Nicole L.
    Chesson, Melissa M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (12) : 2023 - 2027
  • [24] COMPARISON OF SUBCUTANEOUS UNFRACTIONATED HEPARIN WITH A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN(R)) IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND CONTRAINDICATIONS TO COUMARIN
    MONREAL, M
    LAFOZ, E
    OLIVE, A
    DELRIO, L
    VEDIA, C
    [J]. THROMBOSIS AND HAEMOSTASIS, 1994, 71 (01) : 7 - 11
  • [25] Safety and Efficacy of High-Dose Unfractionated Heparin for Prevention of Venous Thromboembolism in Overweight and Obese Patients
    Joy, Mishna
    Tharp, Eileen
    Hartman, Heather
    Schepcoff, Sara
    Cortes, Jennifer
    Sieg, Adam
    Mariski, Mark
    Lee, Yeunju
    Murphy, Meghan
    Ranjbar, Ghazaleh
    Sharaf, Sherouk
    Yau, Gin
    Choi, Huimahn Alex
    Samuel, Sophie
    [J]. PHARMACOTHERAPY, 2016, 36 (07): : 740 - 748
  • [26] Prevention of venous thromboembolism in patients with stroke - enoxaparin vs unfractionated heparin
    Bernstein, Richard A.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (10): : 542 - 543
  • [27] Prevention of venous thromboembolism in patients with stroke—enoxaparin vs unfractionated heparin
    Richard A Bernstein
    [J]. Nature Clinical Practice Neurology, 2007, 3 : 542 - 543
  • [28] COMPARING SUBCUTANEOUS DANAPAROID WITH INTRAVENOUS UNFRACTIONATED HEPARIN FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM - A RANDOMIZED CONTROLLED TRIAL
    DEVALK, HW
    BANGA, JD
    WESTER, JWJ
    BROUWER, CB
    VANHESSEN, MWJ
    MEUWISSEN, OJAT
    HART, HC
    SIXMA, JJ
    NIEUWENHUIS, HK
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (01) : 1 - 9
  • [29] SUBCUTANEOUS FIXED DOSE OF ENOXAPARINE (E) VERSUS INTRAVENOUS ADJUSTED DOSE OF UNFRACTIONATED HEPARIN (UH) IN THE TREATMENT OF DEEP VENOUS THROMBOSIS (DVT)
    SIMONNEAU, G
    [J]. THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 754 - 754
  • [30] THE OUTCOMES OF USING FIXED-DOSE NOMOGRAM-GUIDED UNFRACTIONATED HEPARIN THERAPY IN ELDERLY PATIENTS IN COMPARISON WITH YOUNGER PATIENTS
    Acibuca, Aynur
    Muderrisoglu, Ibrahim Haldun
    [J]. TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2020, 23 (03): : 308 - 316
12345